Advertisement

The Latest

Marietta, Ga.-based Wellstar Health System is making changes to its leadership structure amid 761 job cuts. “We are recalibrating our leadership structure to reduce administrative layers and better align with industry best practices, which means that some Wellstar leaders’ roles…

Two acquisitions announced a day apart this week point to a broader consolidation wave among AI-native virtual care companies, as scaled platforms move to acquire clinical data, provider networks and health plan capabilities rather than build them from scratch. Included…

Drugmakers have pushed back their resupply estimates for carboplatin, one of four chemotherapy drugs in a monthslong shortage, with some formulations now not expected to return until 2027. Cisplatin, carboplatin, oxaliplatin and ifosfamide, which form the backbone of treatment for…

Altamonte Springs, Fla.-based AdventHealth has named three executives to new CEO roles across its West Florida Division, according to a July 30 LinkedIn post published from Regional CEO Jennifer Wandersleben. William Villegas was named CEO of AdventHealth Dade City (Fla.).…

Utah has the highest share of hospitals with five stars under CMS’ Overall Hospital Quality Star Ratings system, a Becker’s analysis shows. CMS updated its star ratings on May 13. Of the 3,182 hospitals rated nationally, 384 received five stars.…

Hospitals and health systems are adding new executive positions to address the growing demands of artificial intelligence governance, cybersecurity and data management.  Many of the roles being created are inaugural appointments, reflecting a shift in how organizations are structuring technology…

Healthcare data breaches cost an average of $6.64 million in 2026. According to IBM’s “Cost of a Data Breach Report 2026,” conducted by Ponemon Institute, that figure marks healthcare’s 13th consecutive year as the costliest industry for data breaches, though…

The Health Resources and Services Administration has revised its 340B Rebate Model Pilot Program, establishing a voluntary pathway for qualifying drug manufacturers to provide 340B ceiling prices through rebates rather than upfront discounts for a limited group of covered outpatient…

Advertisement